Kimberly Brown, MD
Neurological Surgery · Albany, GANPI 1205829009
Payments from drug & device makers
Across 119 payments — averaging $94.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Medical Device Business Services, Inc.$2K
- Johnson & Johnson$544
- Organogenesis Inc.$288
- AstraZeneca$261
- Medtronic$98
- plus $457 from 10 others
What the payments were for
- Travel & lodging$6,23756%
- Food & beverage$4,97944%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 65 | $7,944 |
| Medical Device Business Services, Inc. | 6 | $1,624 |
| Johnson & Johnson | 14 | $544 |
| Organogenesis Inc. | 4 | $288 |
| AstraZeneca(2 entities) | 9 | $261 |
| Medtronic | 1 | $98 |
| DJO, LLC | 5 | $94 |
| Novocure Inc. | 2 | $90 |
| Sanara Medtech Inc. | 3 | $75 |
| Baxter Healthcare | 2 | $68 |
| Integra Lifesciences Corporation | 3 | $44 |
| Zimmer Biomet | 1 | $22 |
| Biogen | 1 | $19 |
| Portola Pharmaceuticals, LLC | 1 | $18 |
| Lemaitre Vascular, Inc. | 1 | $14 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,216 in reported general payments places this provider in the 60th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 98 | $1,024 |
| Gabapentin | 103 | $713 |
| Tizanidine Hcl | 49 | $422 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $264 |
| Duloxetine Hcl | 20 | $253 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $207 |
| Levetiracetam | 11 | $114 |
| Amitriptyline Hcl | 12 | $114 |
| Esomeprazole Magnesium | 13 | $109 |
| Baclofen | 14 | $92 |
| Amlodipine Besylate | 16 | $39 |
| Lisinopril | 12 | $21 |
| Diazepam | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Albany
- Regis HaidAtlanta$25.5M
- Rishi GuptaMarietta$3.5M
- John CowanRome$3.2M
- Thomas MorrisonAtlanta$2.8M
- Arthur GrigorianAtlanta$2M
- Christopher TomarasAtlanta$1.5M
- Betsy GrunchGainesville$1.2M
- Daniel RefaiAtlanta$1.2M
- Gerald RodtsAtlanta$1.2M
- James RobinsonAtlanta$993K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.